Human osteopontin: potential clinical applications in cancer (Review)

Hao, Chengcheng, Cui, Yuxin, Owen, Sionen, Li, Wenbin, Cheng, Shan and Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 2017. Human osteopontin: potential clinical applications in cancer (Review). International Journal of Molecular Medicine 10.3892/ijmm.2017.2964

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (588kB) | Preview

Abstract

Human osteopontin (OPN) is a glycosylated phosphoprotein which is expressed in a variety of tissues in the body. In recent years, accumulating evidence has indicated that the aberrant expression of OPN is closely associated with tumourigensis, progression and most prominently with metastasis in several tumour types. In this review, we present the current knowledge on the expression profiles of OPN and its main splice variants in human cancers, as well as the potential implications in patient outcome. We also discuss its putative clinical application as a cancer biomarker and as a therapeutic target.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Publisher:	Spandidos Publications
ISSN:	1107-3756
Funders:	cancer research Wales, cardiff university china medical Scholarship, life Science research network for Wales (lSrnW) and the Albert Hung foundation
Date of First Compliant Deposit:	24 April 2017
Date of Acceptance:	10 April 2017
Last Modified:	04 May 2023 19:54
URI:	https://orca.cardiff.ac.uk/id/eprint/100043

Citation Data

Cited 65 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item